Close Menu

NEW YORK (GenomeWeb) – Binx Health today announced that it has received CE marking for a chlamydia and gonorrhea (CT/NG) test that runs on its Binx io point-of-care platform and delivers laboratory-quality results in about 30 minutes.

"Rapid results equal rapid, appropriate treatment," Howard Heller, Binx Health's chief medical officer, said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.